Vaccine hesitancy in the time of COVID: How to manage a public health threat

Cleve Clin J Med. 2024 Sep 3;91(9):565-573. doi: 10.3949/ccjm.91a.24062.

Authors

H Clifford Lane¹, Steven M Gordon²

Affiliations

¹ Clinical Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD clane@nih.gov.
² Chair, Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

PMID: 39227084
DOI: 10.3949/ccjm.91a.24062

No abstract available

MeSH terms

COVID-19 Vaccines*
COVID-19* / epidemiology
COVID-19* / prevention & control
COVID-19* / psychology
Humans
Public Health*
SARS-CoV-2
Vaccination Hesitancy* / psychology

Substances

COVID-19 Vaccines